pmc logo image
Logo of bmjcredBMJ helping doctors make better decisionsSearchLatest content

Formats:

Br Med J (Clin Res Ed). 1982 November 6; 285(6351): 1304–1306.
PMCID: PMC1500200
Haemolytic uraemic syndrome: therapeutic effect of plasma infusion.
R Misiani, A C Appiani, A Edefonti, E Gotti, A Bettinelli, M Giani, E Rossi, G Remuzzi, and G Mecca
Abstract
The therapeutic effect of plasma infusion was evaluated in 10 children and seven adults with haemolytic uraemic syndrome. All but one patient responded to this treatment with rapid disappearance of haematological abnormalities. The patient who apparently failed to respond to plasma infusion obtained complete remission of the disease after plasmapheresis. Although 15 of the 17 patients were anuric or oliguric on admission, renal function recovered completely in eight children and two adults. Seven patients showed residual chronic renal failure and two required long-term maintenance haemodialysis. Treatment with plasma was also successful in patients with relapses or recurrent episodes. Plasma infusion is a promising therapeutic approach for the haemolytic uraemic syndrome and deserves further study in clinical trials.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (669K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Habib R, Mathieu H, Royer P. Le syndrome hémolytique et urémique de l'enfant,. Aspects cliniques et anatomiques dans 27 observations. Nephron. 1967;4(3):139–172. [PubMed]
  • Gervais M, Richardson JB, Chiu J, Drummond KN. Immunofluorescent and histologic findings in the hemolytic uremic syndrome. Pediatrics. 1971 Feb;47(2):352–359. [PubMed]
  • Morel-Maroger L, Kanfer A, Solez K, Sraer JD, Richet G. Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome): clinicopathologic study in 20 adults. Kidney Int. 1979 May;15(5):548–558. [PubMed]
  • Ponticelli C, Imbasciati E, Tarantino A, Graziani G, Redaelli B. Post-partum renal failure with microangiopathic haemolytic anaemia. Long-term survival after anticoagulant therapy. Nephron. 1972;9(1):27–41. [PubMed]
  • Luke RG. Letter: Treatment of adult hemolytic uremic syndrome. N Engl J Med. 1976 Feb 12;294(7):396. [PubMed]
  • Monnens L, Kleynen F, Van Munster P, Schretlen E, Bonnerman A. Coagulation studies and streptokinase therapy in the haemolytic-uraemic syndrome. Helv Paediatr Acta. 1972 Apr;21(1):45–54. [PubMed]
  • Stuart J, Winterborn MH, White RH, Flinn RM. Thrombolytic therapy in haemolytic--uraemic syndrome. Br Med J. 1974 Jul 27;3(5925):217–221. [PubMed]
  • Katz J, Krawitz S, Sacks PV, Levin SE, Thomson P, Levin J, Metz J. Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancy. J Pediatr. 1973 Nov;83(5):739–748. [PubMed]
  • Harker LA, Slichter SJ. Platelet and fibrinogen consumption in man. N Engl J Med. 1972 Nov 16;287(20):999–1005. [PubMed]
  • Arenson EB, Jr, August CS. Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole. J Pediatr. 1975 Jun;86(6):957–961. [PubMed]
  • Thorsen CA, Rossi EC, Green D, Carone FA. The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function. Am J Med. 1979 Apr;66(4):711–716. [PubMed]
  • Kaplan BS, Drummond KN. The hemolytic-uremic syndrome is a syndrome. N Engl J Med. 1978 Apr 27;298(17):964–966. [PubMed]
  • Bukowski RM, Hewlett JS, Harris JW, Hoffman GC, Battle JD, Jr, Silverblatt E, Yang IY. Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura. Semin Hematol. 1976 Jul;13(3):219–232. [PubMed]
  • Pisciotta AV, Garthwaite T, Darin J, Aster RH. Treatment of thrombotic thrombocytopenic purpura by exchange transfusion. Am J Hematol. 1977;3:73–82. [PubMed]
  • Bukowski RM, King JW, Hewlett JS. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood. 1977 Sep;50(3):413–417. [PubMed]
  • Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med. 1977 Dec 22;297(25):1386–1389. [PubMed]
  • Remuzzi G, Misiani R, Marchesi D, Livio M, Mecca G, de Gaetano G, Donati MB. Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet. 1978 Oct 21;2(8095):871–872. [PubMed]
  • Remuzzi G, Misiani R, Mecca G, de Gaetano G, Donati MB. Thrombotic thrombocytopenic purpura--a deficiency of plasma factors regulating platelet-vessel-wall interaction? N Engl J Med. 1978 Aug 10;299(6):311. [PubMed]
  • Machin SJ, Defreyn G, Chamone DA, Vermylen J. Plasma 6-keto-PGF1 alpha levels after plasma exchange in thrombotic thrombocytopenic purpura. Lancet. 1980 Mar 22;1(8169):661–661. [PubMed]
  • Remuzzi G, Misiani R, Marchesi D, Livio M, Mecca G, de Gaetano G, Donati MD. Treatment of the hemolytic uremic syndrome with plasma. Clin Nephrol. 1979 Dec;12(6):279–284. [PubMed]
  • Kaplan BS, Thomson PD, de Chadarévian JP. The hemolytic uremic syndrome. Pediatr Clin North Am. 1976 Nov;23(4):761–777. [PubMed]
  • Kaplan BS, Katz J, Krawitz S, Lurie A. An analysis of the results of therapy in 67 cases of the hemolytic-uremic syndrome. J Pediatr. 1971 Mar;78(3):420–425. [PubMed]
  • Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET. The hemolytic-uremic syndrome. Nephron. 1973;11(2):174–192. [PubMed]
  • Sorrenti LY, Lewy PR. The hemolytic-uremic syndrome: experience at a center in the Midwest. Am J Dis Child. 1978 Jan;132(1):59–62. [PubMed]
  • Dolislager D, Tune B. The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome. Am J Dis Child. 1978 Jan;132(1):55–58. [PubMed]
  • Goldstein MH, Churg J, Strauss L, Gribetz D. Hemolytic-uremic syndrome. Nephron. 1979;23(6):263–272. [PubMed]
  • Remuzzi G, Mecca G, Livio M, de Gaetano G, Donati MB, Pearson JD, Gordon JL. Prostacyclin generation by cultured endothelial cells in haemolytic uraemic syndrome. Lancet. 1980 Mar 22;1(8169):656–657. [PubMed]